Medigene Immunotherapies GmbH

MEDIGENE

Pharmaceutical and veterinary preparations namely, cellular preparations, T-cell preparations and DC (dendritic cell) preparations for the treatment of cancer and use in immunotherapy; medical compositions for the treatment of hematological and solid tumors, tumor precursors; test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of antibodies, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of soluble T-cell receptors, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of genetically modified cells and test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods;Color is not claimed as a feature of the mark.;Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto for medical purposes;Services in molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits in the field of hematological and solid tumor immunology; biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific and therapeutic purposes; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients;

MEDIGENE IMMUNOTHERAPIES

Medicines for humans and animals, vaccines, serums for medical purposes, and diagnostic preparations for medical purposes for treating cancer, in particular manufactured using molecular biological, genetic engineering and biotechnological methods; test kits for principally comprised of diagnostic preparations for medical purposes that contains at least one of soluble t-cell receptors, and genetically modified cells for determining the type and existence of a tumour in a patient, in particular manufactured using molecular biological, genetic engineering and biotechnological methods; proteins and cells, namely, immune cells carrying a target specific effector protein, protein conjugates, peptides, enzymes and enzyme preparations, in particular antibodies and t-cell proteins, all for medical purposes; t-cells, dendritic cells other immune system cells, and viruses, all for medical purposes;plant extracts for medical purposes; medicines, vaccines, adjuvants, serums all for immunotherapy and the treatment of benign and malignant tumours, haematological tumours, inflammatory disorders, neurodegenerative disorders, and autoimmune conditions in particular manufactured using molecular biological, genetic engineering and biotechnological methods; test kits and diagnostic agents comprised of medical diagnostic preparations that contain at least one of soluble t-cell receptors and genetically modified cells for the diagnosis of benign and malignant tumours, haematological tumours, inflammatory disorders, neurodegenerative disorders, and autoimmune conditions in particular manufactured using molecular biological, genetic engineering and biotechnological methods;MEDI GENE IMMUNOTHERAPY'S;Medical analysis and medical consulting in connection with the treatment of individuals, in particular in the field of precancerous cells, benign and malignant tumours, autoimmune diseases and immunotherapy;IMMUNOTHERAPIES;Custom molecular biology and biotechnology laboratory services, in particular custom research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, genetic engineering and biotechnological methods to the specifications of others, and in the field of screening for pharmaceutically active components; development of custom test procedures and custom test kits in the field of biotechnology and medicine to the specification of others;

MEDIGENE IMMUNOTHERAPIES

Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy;MEDIGENE IMMUNO THERAPIES;Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine;Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy;IMMUNOTHERAPIES;Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine;